Reata Pharmaceuticals

All the email addresses for reatapharma.com

{first}.{last}@reatapharma.com
13 email addresses
http://firstwordpharma.com/node/1504861 October 10, 2017
http://globenewswire.ca/news-release/2017/09/13/1120523/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma.html October 10, 2017
http://reatapharma.com/reata-announces-initial-phase-2-pulmonary-arterial-hypertension-data-for-bardoxolone-methyl-and-planned-initiation-of-phase-3-study January 1, 2016
http://reatapharma.com/contact-us January 1, 2016
http://marketwired.com/press-release/reata-enrolls-first-patient-moxie-study-phase-2-3-study-examining-rta-408-friedreichs-1987066.htm August 8, 2017
http://globenewswire.com/news-release/2017/06/01/1005786/0/en/reata-pharmaceuticals-inc-announces-positive-data-from-part-one-of-moxie-trial-of-omaveloxolone-for-friedreich-s-ataxia.html October 10, 2017
http://news.learnatchina.com/tag/cbt/page/2 May 5, 2016
http://formkit.com/wire/reata-pharmaceuticals-inc-announces-second-quarter-2016-financial-and-operating-results August 8, 2016
http://biospace.com/news/reata-pharmaceuticals-inc-s-bardoxolone-methyl/463868 September 9, 2017
http://reatapharma.com/legal-message January 1, 2016
http://reatapharma.com/reata-to-present-initial-phase-2-data-on-bardoxolone-methyl-a-novel-experimental-therapy-for-pulmonary-hypertension-used-in-patients-on-stable-background-pah-therapy January 1, 2016
http://marketwired.com/press-release/reata-announces-initiation-phase-2-studies-examining-rta-408-treatment-friedreichs-ataxia-1952199.htm September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-pricing-of/464426 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-closing-of/464882 September 9, 2017
http://marketwired.com/press-release/reata-enrolls-first-patient-primrose-study-phase-2-study-examining-rta-408-breast-cancer-1932722.htm September 9, 2017
http://reatapharma.com/reata-enrolls-first-patient-with-pulmonary-hypertension-associated-with-interstitial-lung-disease-in-lariat-a-phase-2-study-examining-bardoxolone-methyl-for-the-treatment-of-patients-with-pulmonary-h January 1, 2016
http://marketwired.com/press-release/reata-pharmaceuticals-receives-orphan-drug-designation-bardoxolone-methyl-from-us-fda-2008458.htm September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-proposed/464219 September 9, 2017
http://marketwired.com/press-release/reata-announces-initial-phase-2-pulmonary-arterial-hypertension-data-bardoxolone-methyl-2067451.htm September 9, 2017
http://marketwatch.com/story/reata-announces-the-initiation-of-phase-2-studies-examining-rta-408-for-the-treatment-of-friedreichs-ataxia-and-mitochondrial-myopathies-2014-09-30 September 9, 2017
http://mitoaction.org/blog/2016-mito-town-meeting March 3, 2016
http://news.learnatchina.com/tag/growth May 5, 2016
http://news.learnatchina.com/tag/mobile-learning May 5, 2016
http://news.learnatchina.com/2016052616327.html May 5, 2016
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-pricing-of-class-a-common-stock-public-offering-20170726-01938 August 8, 2017
http://nasdaq.com/press-release/reatas-bardoxolone-methyl-demonstrated-improved-kidney-function-in-patients-with-alport-syndrome-i-20170724-00299 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-bardoxolone-methyl-for-the-treatmen-20170710-00272 August 8, 2017
http://nasdaq.com/press-release/reata-announces-first-patient-enrolled-in-phase-3-cardinal-trial-of-bardoxolone-methyl-in-the-20170807-01298 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-proposed-public-offering-of-class-a-common-stock-20170725-01395 August 8, 2017
http://benzinga.com/pressreleases/16/10/g8537164/reata-enrolls-first-patient-in-phase-3-catalyst-trial-of-bardoxolone-me May 5, 2017
http://thenewsreports.com/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma/32035/staff October 10, 2017
http://firstwordpharma.com/node/1504861 October 10, 2017
http://globenewswire.ca/news-release/2017/09/13/1120523/0/en/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-omaveloxolone-for-the-treatment-of-malignant-melanoma.html October 10, 2017
http://reatapharma.com/contact-us January 1, 2017
http://globenewswire.com/news-release/2017/06/01/1005786/0/en/reata-pharmaceuticals-inc-announces-positive-data-from-part-one-of-moxie-trial-of-omaveloxolone-for-friedreich-s-ataxia.html October 10, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-s-bardoxolone-methyl/463868 September 9, 2017
http://formkit.com/wire/reata-pharmaceuticals-inc-announces-second-quarter-2016-financial-and-operating-results November 11, 2016
http://biospace.com/news/reata-pharmaceuticals-inc-announces-pricing-of/464426 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-closing-of/464882 September 9, 2017
http://biospace.com/news/reata-pharmaceuticals-inc-announces-proposed/464219 September 9, 2017
http://news.learnatchina.com/2016052616327.html February 2, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-pricing-of-class-a-common-stock-public-offering-20170726-01938 August 8, 2017
http://nasdaq.com/press-release/reatas-bardoxolone-methyl-demonstrated-improved-kidney-function-in-patients-with-alport-syndrome-i-20170724-00299 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-receives-orphan-drug-designation-for-bardoxolone-methyl-for-the-treatmen-20170710-00272 August 8, 2017
http://nasdaq.com/press-release/reata-announces-first-patient-enrolled-in-phase-3-cardinal-trial-of-bardoxolone-methyl-in-the-20170807-01298 August 8, 2017
http://nasdaq.com/press-release/reata-pharmaceuticals-inc-announces-proposed-public-offering-of-class-a-common-stock-20170725-01395 August 8, 2017
http://investors.reatapharma.com/phoenix.zhtml October 10, 2016
http://benzinga.com/pressreleases/16/10/g8537164/reata-enrolls-first-patient-in-phase-3-catalyst-trial-of-bardoxolone-me May 5, 2017

Please log in to uncover the email addresses, access the 13 results for reatapharma.com, filters and more.

Create a free account

Already have an account? Sign in

More information about reatapharma.com

Language of the website: English

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.